The Centers for Medicare & Medicaid Services Aug. 3 issued a proposed rule that would update physician fee schedule payments for calendar year 2021. The rule also included several proposals to implement year five of the quality payment program created by the Medicare Access and CHIP Reauthorization Act of 2015.

Among other proposals, CMS would:

  • Reduce the PFS conversion factor by 10.61% for CY 2021;
  • Add services to the Medicare telehealth list of services and make other changes to retain certain COVID-19 telehealth flexibilities;
  • Increase payment rates for office/outpatient evaluation and management visits;
  • Implement changes to enable health care professionals to practice at the top of their licenses;
  • Delay the next Clinical Laboratory Fee Schedule data reporting period by an additional year so that hospital outreach laboratories would not need to report private payer data until Jan. 1, 2022 through March 31, 2022;
  • Eliminate the phase-in of CLFS payment cuts in 2021; and
  • Implement provisions of the Substance Use-disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, including Medicare coverage for opioid treatment programs, screening for substance use disorder in Medicare physicals, and electronic prescribing of controlled substances.

Comments on the proposed rule are due by Oct. 5.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services July 2 announced that Maryland, Vermont and Connecticut will be the first participants in the States Advancing…
Headline
The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The Centers for Medicare & Medicaid Services July 8 announced over 400 participants in a new model focused on improving dementia care. The Guiding an…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
A Mississippi judge July 1 denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B…